Intratumoral Injections of LL37 for Melanoma

Summary

The goal of this clinical research study is to find the appropriate dose of LL37 that can be given to patients with melanoma. Researchers also want to learn if LL37 can stimulate the immune system to help control the disease.

Timeline

Start

2015-07-08

Primary completion

2020-11-24

Completion

2020-11-24

Drugs

Indications